DePuy Synthes launches matrixsternum fixation system for enhanced chest stability following cardiac surgery

DePuy Synthes launches matrixsternum fixation system for enhanced chest stability following cardiac surgery

DePuy Synthes, The Orthopaedics Company of Johnson & Johnson and part of Johnson & Johnson MedTech, has announced the launch of the MatrixSTERNUM Fixation System, a plate and screw fixation system to help stabilise and secure the front part of the chest wall after procedures like open-heart surgery and chest surgery. This advanced system is designed to meet patients’ needs in the operating room by providing stronger locking strength, faster chest fixation and thinner, low-profile plates as compared to competitive offerings. 

Every year in the US, approximately 200,000 people undergo coronary artery bypass graft (CABG) surgery, making it the most common type of heart surgery. As the demand for improved chest fixation techniques increases, there is a clear need for innovations that promote better healing, reduce complications and speed up recovery. Recent research indicates that using rigid plates for chest fixation can help lower complications for patients who are at high risk, improve survival rates both during and after surgery and shorten hospital stays. 

“We are committed to developing products that not only meet but exceed the specific needs of heart surgery patients and healthcare providers,” said Oray Boston, Worldwide President, DePuy Synthes Trauma, Extremities, Craniomaxillofacial, Animal Health and Sports. “The MatrixSTERNUM Fixation System is a new advancement for post-operative chest stabilisation, with stronger, faster and thinner solutions that streamline the procedure and offer surgeons greater flexibility to meet patient needs.” 

Click below to share this article